Related Experiment Video

Updated: Jun 2, 2026

Expression and Purification of Virus-like Particles for Vaccination
06:17

Expression and Purification of Virus-like Particles for Vaccination

Published on: June 2, 2016

Agreement on a pandemic influenza preparedness framework for the sharing of viruses and benefit sharing

1

  • 1European Centre for Disease Prevention and Control, Stockholm, Sweden. eurosurveillance@ecdc.europa.eu

Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin
|April 30, 2011
PubMed

Insights

The World Health Organization (WHO) established a pandemic influenza preparedness framework to ensure equitable access to vaccines and antiviral drugs. This agreement facilitates global virus sharing and strengthens preparedness for future influenza pandemics.

Area of Science:

  • Public Health
  • Epidemiology
  • International Health Policy

Background:

  • Negotiations for a pandemic influenza preparedness framework began in November 2007, involving 193 WHO member states.
  • Concerns regarding equitable benefit sharing had previously hindered the timely global dissemination of influenza sequences.
  • The framework addresses the sharing of viruses within the WHO Laboratory Global Influenza Surveillance Network (GISN).

Discussion:

  • The framework mandates regular contributions from industry partners.
  • It regulates access to essential pandemic resources, including vaccines, antiviral drugs, and diagnostic kits.
  • Special consideration is given to lower-income countries to ensure equitable access.

Key Insights:

  • An agreement was reached on April 16, 2011, by a WHO working group.
  • The framework aims to strengthen global preparedness for future influenza pandemics.
  • The agreement will be presented for approval at the World Health Assembly in May 2011.

Outlook:

  • The established framework is expected to enhance international collaboration in pandemic influenza surveillance and response.
  • It promotes a more equitable distribution of pandemic preparedness resources globally.
  • Further details and implications are available from the European Centre for Disease Prevention and Control.

More Related Videos

Production of High-Titer Infectious Influenza Pseudotyped Particles with Envelope Glycoproteins from Highly Pathogenic H5N1 and Avian H7N9 Viruses08:10

Production of High-Titer Infectious Influenza Pseudotyped Particles with Envelope Glycoproteins from Highly Pathogenic H5N1 and Avian H7N9 Viruses

Published on: January 15, 2020

Multi-target Parallel Processing Approach for Gene-to-structure Determination of the Influenza Polymerase PB2 Subunit22:10

Multi-target Parallel Processing Approach for Gene-to-structure Determination of the Influenza Polymerase PB2 Subunit

Published on: June 28, 2013

Related Concept Videos

Viral Recombination00:57

Viral Recombination

Cells are sometimes infected by more than one virus at once. When two viruses disassemble to expose their genomes for replication in the same cell, similar regions of their genomes can pair together and exchange sequences in a process called recombination. Alternatively, viruses with segmented genomes can swap segments in a process called reassortment.
Influenza01:27

Influenza

Influenza is an acute, highly communicable viral disease that affects the respiratory tract and is responsible for seasonal epidemics worldwide. Influenza A is the most prevalent type associated with widespread outbreaks and is subtyped based on two surface glycoproteins: hemagglutinin (H) and neuraminidase (N), as in H1N1. These glycoproteins are essential for viral infectivity, transmission, and immune recognition. Transmission occurs primarily through respiratory droplets and contaminated...
Inhibitors Of Virion Release01:25

Inhibitors Of Virion Release

Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...